Our B2i Digital Featured Company, Unicycive Therapeutics (NASDAQ: $UNCY) https://b2idigital.com/unicycive, is dedicated to advancing novel therapies for patients with kidney disease. In a recent video, Dr. Glenn Chertow, a distinguished nephrologist and the Norman S. Coplon/Satellite Healthcare Professor of Medicine at Stanford University, shares his perspective on the challenges facing patients and the potential for Unicycive’s pipeline. Dr. Chertow expresses confidence in Unicycive’s leadershi
0:46
Our B2i Digital Featured Company, Unicycive Therapeutics (NASDAQ…
74 viewsMay 2, 2024
FacebookB2i Digital
Unicycive Therapeutics (Nasdaq: UNCY) announced the upcoming presentation of new data at ASN Kidney Week 2025 demonstrating that oxylanthanum carbonate (OLC) dramatically reduces pill burden for dialysis patients with hyperphosphatemia. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://lnkd.in/eg9U-h4f. The company will present data from its open-label pivotal trial showing that patients switching to OLC experienced a 7-fold reduction in pill v
0:15
Unicycive Therapeutics (Nasdaq: UNCY) announced the upcoming p…
4.9K views4 months ago
FacebookB2i Digital
In this episode, Unicycive Therapeutics founder and CEO Dr. Shalabh Gupta discusses the current unmet needs in kidney diseases and Unicycive’s innovative approaches to addressing them. Listen now at https://buff.ly/cPzHKdn 🎙️ | Xtalks Webinars
0:45
In this episode, Unicycive Therapeutics founder and CEO Dr…
7 viewsMar 26, 2025
FacebookXtalks Webinars
Unicycive's Important Work
0:33
Unicycive's Important Work
1.2K viewsMar 1, 2024
YouTubeUnicycive
Unicycive Therapeutics (Nasdaq: UNCY) recently released an updated company presentation highlighting several financial aspects of the biotechnology company. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. Highlights from the investor presentation include: • Unaudited cash and cash equivalents of $22.3 million as of June 30, 2025 • Cash runway currently expected into 2H 2026 • Potential future funding of up to $102 mi
0:20
Unicycive Therapeutics (Nasdaq: UNCY) recently released an updat…
1.3K views6 months ago
FacebookB2i Digital
Unicycive Therapeutics (Nasdaq: UNCY) announced Q3 2025 results and remains on track to resubmit its NDA for oxylanthanum carbonate (OLC) by year-end. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. The company reported solid progress on multiple fronts, including resolution of FDA manufacturing concerns, presentation of compelling pill burden reduction data at ASN Kidney Week 2025, and a strengthened balance sheet w
0:10
Unicycive Therapeutics (Nasdaq: UNCY) announced Q3 2025 result…
155 views4 months ago
FacebookB2i Digital
Dr. Shalabh Gupta, Founder, Chairman & CEO of Unicycive Therapeutics, took the stage at the 2025 Healthcare Summit to discuss the crucial pitfalls and opportunities shaping the medical landscape. Presented by Unicycive Learn More: https://bit.ly/4p9AEya | Forbes
0:12
Dr. Shalabh Gupta, Founder, Chairman & CEO of Unicycive The…
672 views3 months ago
FacebookForbes
Unicycive Therapeutics, Inc.: Unicycive Therapeutics Announce…
3 months ago
finanznachrichten.de
0:50
Dr. Shalabh Gupta, Founder, Chairman & CEO of Unicycive The…
537 views3 months ago
FacebookForbes
2:48
With "living therapeutics", we can deploy live cells from a patients o…
9.2K viewsJun 10, 2021
FacebookUCSF
1:37
Mighty Mitochondria: $UNCY Is Developing A Novel Drug for Kidn…
2 viewsFeb 2, 2023
DailymotionBenzinga
Novel Therapeutics
Jul 16, 2021
ox.ac.uk
0:58
What does the recent CRL news mean for Unicycive
56.8K views7 months ago
YouTubeB2i Digital, Inc.
4:17
Interview with Dr. Glenn Chertow
2.7K viewsMar 1, 2024
YouTubeUnicycive
Company - Intensity Therapeutics
Apr 28, 2023
intensitytherapeutics.com
Pipeline - Providence Therapeutics
Dec 11, 2023
providencetherapeutics.com
Solvonis Therapeutics is advancing CNS pipeline - ICYMI
5 months ago
proactiveinvestors.com
EV Therapeutics - Extracellular Vesicle-based Immunotherapy
Dec 29, 2020
evtherapeutics.com
6:59
NASDAQ: UNCY Unicycive’s Doug Jermasek, EVP-Corporate Develop…
1 viewsNov 8, 2022
DailymotionBenzinga
0:18
Podcast: Unicycive Therapeutic
10 views4 months ago
YouTubeLevi & Korsinsky
Solvonis Therapeutics CEO on transformational first half, SVN-00…
6 months ago
proactiveinvestors.co.uk
1:11
From advancing molecules to optimizing clinical trials and patie…
723 views1 month ago
FacebookForbes
0:14
Unicycive Therapeutics Resubmits NDA for Oxylanthanum Carbonate…
1.2K views3 months ago
YouTubeB2i Digital, Inc.
7:15
I'm impressed by what I see with Axsome Therapeutics, says Jim C…
Feb 6, 2024
CNBCJim Cramer
7:00
Unicycive Therapeutics UNCY PDUFA Date Summary 02Feb2026
204 views1 month ago
YouTubeRunningRobert
8:09
NASDAQ: $UNCY Pivotal For The People: An Exciting Clinical Trial …
3 viewsFeb 15, 2023
DailymotionBenzinga
COVID-19 Treatments and Therapeutics
Feb 25, 2021
hhs.gov
1:05
"One in seven adults in the U.S. suffers from Chronic Kidney Disea…
528 views3 months ago
FacebookForbes
30:49
Unicycive Therapeutics, Inc. (Nasdaq: UNCY): Virtual Investor …
326 viewsSep 19, 2024
YouTubeOTC Markets Group
22:11
Unicycive Therapeutics Fireside Chat @ Lytham Partners 2026 Inve…
100 views2 months ago
YouTubeLytham Partners
See more videos
Static thumbnail place holder